Related Experiment Video
Updated: May 22, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis
Kui Ming Chan1, Hoi Leong Xavier Wong, Guoxiang Jin
1Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, China.
Abstract:
MMP14 encodes a membrane-tethered metalloproteinase MT1-MMP, capable of remodeling the extracellular matrix and modulating receptors on the cell surface. Loss of MT1-MMP results in craniofacial abnormalities. Here we show that MT1-MMP forms a complex with FGFR2 and ADAM9 in osteoblasts and proteolytically inactivates ADAM9, hence protecting FGFR2 from ADAM9-mediated ectodomain shedding on the cell surface. In Mmp14-/- osteoblasts, FGF-induced proliferation and downstream signaling are specifically compromised, in conjunction with ADAM9 upregulation and FGFR2 shedding. The retarded parietal growth in Mmp14-/- embryos starts at 15.5 dpc, attributable to the impaired FGFR2 signaling due to increased shedding mediated by ADAM9. Adam9 depletion completely rescues the defective FGFR2 signaling and largely restores calvarial bone growth in Mmp14-/- embryos. These data reveal a regulatory paradigm for FGRF2 signaling and identify MT1-MMP as a critical negative modulator of ADAM9 activity to maintain FGFR2 signaling in calvarial osteogenesis.
Insights
Matrix metalloproteinase-14 (MT1-MMP) protects FGFR2 signaling in osteoblasts by inactivating ADAM9. This maintains calvarial bone growth, and its absence causes craniofacial abnormalities.
Area of Science:
- Molecular Biology
- Developmental Biology
- Biochemistry
Background:
- Matrix metalloproteinase-14 (MT1-MMP) is crucial for extracellular matrix remodeling and cell surface receptor modulation.
- Loss of MT1-MMP function leads to craniofacial abnormalities, indicating its importance in skeletal development.
Purpose of the Study:
- To elucidate the mechanism by which MT1-MMP regulates FGFR2 signaling in osteoblasts.
- To investigate the role of MT1-MMP in calvarial bone development and its interaction with ADAM9 and FGFR2.
Main Methods:
- Investigated protein interactions between MT1-MMP, ADAM9, and FGFR2 in osteoblasts.
- Analyzed FGF-induced proliferation and signaling pathways in Mmp14-/- osteoblasts.
- Assessed calvarial bone growth in Mmp14-/- embryos and the effect of Adam9 depletion.
Main Results:
- MT1-MMP forms a complex with FGFR2 and ADAM9, proteolytically inactivating ADAM9 and preventing FGFR2 shedding.
- Mmp14-/- osteoblasts exhibit compromised FGF-induced proliferation and signaling due to ADAM9 upregulation and FGFR2 shedding.
- MT1-MMP deficiency causes retarded parietal bone growth starting at 15.5 dpc, linked to impaired FGFR2 signaling.
- Adam9 depletion rescues FGFR2 signaling and restores calvarial bone growth in Mmp14-/- embryos.
Conclusions:
- MT1-MMP acts as a critical negative regulator of ADAM9 activity, preserving FGFR2 signaling essential for calvarial osteogenesis.
- This study reveals a novel regulatory mechanism for FGFR2 signaling involving MT1-MMP and ADAM9 in bone development.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
